Skip to Primary Navigation

FDA Commissioner Marty Makary out following policy dispute

A photo of FDA Commissioner Marty Markary looking off into space in front of an American Flag.
Photo: Anna Moneymaker/Getty Images

Makary stepped down amid a widening rift over tobacco regulation and a series of contentious decisions that reshaped the FDA’s internal politics.

Dr Marty Makary resigned Tuesday as commissioner of the US Food and Drug Administration (FDA) after weeks of internal pressure and disagreement with the administration. Kyle Diamantas, the agency’s top food regulator, was named acting commissioner.

Makary’s departure followed conflict over the authorization of fruit‑flavored e‑cigarettes, a policy he

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience